Glostrup / Gilbertsville / Tokyo / Jena / Heidelberg / JOBLING ET / Townsville City / Basel / Braunschweig / Helsinki / Valencia / Walldorf / Zurich / Victoria / Sunnyvale / Cambridge / Parkville / Adelaide / Marly / /
Company
Life Technologies / Adelaide SA / AGE-ASSOCIATED DISEASE / Alcon Laboratories / Vector Laboratories / Roche Diagnostics / Wako Pure Chemical Industries / Qiagen / Canon Incorporated / IPL / Mills S. A. / Ellex R&D Pty Ltd / AMD / Microm International GmbH / Phoenix Research Labs / AMP / Molecular Probes Incorporated / /
Continent
Europe / /
Country
Switzerland / Japan / Australia / United Kingdom / Denmark / Germany / United States / / /
Facility
Ear Hospital / University of Melbourne Animal Ethics Committee / Scale bar / Animal Resources Centre / University of Melbourne / RPE complex / The University of Melbourne / /
IndustryTerm
energy levels / mJ energy treatment / high-energy laser treatment / ultra-low-energy laser / high-energy laser / imaging / treatment of ocular diseases / food / energy / respective treatment groups / low-energy nanosecond laser treatment / laser treatment site / average energy / low-energy nanosecond laser / Tissue processing / in vivo imaging / clinical tools / low-energy-treated mouse retina / low-energy / treated / high-energy treatment confined / laser site / laser injury site / image software / injury site / citrate solutions / laser energy dose / multimodal retinal imaging / lesion site / Laser energy / low-energy laser dose / /
Animal Resources Centre / PNA ( red) / University of Melbourne / Victoria / Human Ethics Committee / American Association of Vision Research and Ophthalmology / †Centre / Melbourne Animal Ethics Committee / Department of Anatomy and Neuroscience / Victorian Eye and Ear Hospital / /
The FASEB Journal • Research Communication Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage A. I. Jobling,*,1 R. H. Guymer,†,1 K. A. Vesse